North China Pharmaceutical Company Ltd. (600812.SS)
CNY 5.49
(-0.54%)
CNY 5.49
(-0.54%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 1.51 Billion CNY | -13.47% |
| 2022 | 796.95 Million CNY | 11.39% |
| 2021 | 1.48 Billion CNY | 3.68% |
| 2020 | 1.37 Billion CNY | 4.1% |
| 2019 | 1.37 Billion CNY | 9.74% |
| 2018 | 1.16 Billion CNY | 30.16% |
| 2017 | 877 Million CNY | 18.0% |
| 2016 | 787.88 Million CNY | 4.78% |
| 2015 | 742.65 Million CNY | -0.18% |
| 2014 | 750.75 Million CNY | 23.82% |
| 2013 | 571.21 Million CNY | 23.03% |
| 2012 | 497.9 Million CNY | -22.42% |
| 2011 | 603.2 Million CNY | -20.62% |
| 2010 | 844.59 Million CNY | -40.49% |
| 2009 | 225.87 Million CNY | 14.83% |
| 2008 | 1.09 Billion CNY | 70.31% |
| 2007 | 663.01 Million CNY | 40.02% |
| 2006 | 515.56 Million CNY | 86.33% |
| 2005 | 279.84 Million CNY | -43.5% |
| 2004 | 324.75 Million CNY | -32.21% |
| 2003 | 717.63 Million CNY | 11.64% |
| 2002 | 637.48 Million CNY | 6.45% |
| 2001 | 572.93 Million CNY | 166.36% |
| 2000 | 225.66 Million CNY | -15.41% |
| 1999 | 266.77 Million CNY | 14.34% |
| 1998 | 233.32 Million CNY | -13.05% |
| 1997 | 268.35 Million CNY | 1.59% |
| 1996 | 264.13 Million CNY | 6.3% |
| 1995 | 248.47 Million CNY | -78.38% |
| 1994 | 1.14 Billion CNY | 519.33% |
| 1993 | 185.52 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | 180.18 Million CNY | -55.93% |
| 2024 Q1 | 201.09 Million CNY | -48.54% |
| 2024 Q2 | 383.18 Million CNY | 103.31% |
| 2023 Q4 | 377.48 Million CNY | 105.53% |
| 2023 FY | - CNY | -13.47% |
| 2023 Q3 | 183.66 Million CNY | -5.52% |
| 2023 Q1 | 189.08 Million CNY | -13.52% |
| 2023 Q2 | 194.39 Million CNY | 2.81% |
| 2022 Q2 | 247.9 Million CNY | 15.73% |
| 2022 FY | - CNY | 11.39% |
| 2022 Q1 | 214.21 Million CNY | 16.15% |
| 2022 Q3 | 191.98 Million CNY | -22.56% |
| 2022 Q4 | 218.63 Million CNY | 13.88% |
| 2021 Q2 | 265.54 Million CNY | 121.15% |
| 2021 Q3 | 209.61 Million CNY | -21.06% |
| 2021 Q4 | 184.44 Million CNY | -12.01% |
| 2021 Q1 | 120.07 Million CNY | -31.12% |
| 2021 FY | - CNY | 3.68% |
| 2020 Q2 | 273.81 Million CNY | 29.89% |
| 2020 Q1 | 210.79 Million CNY | -26.33% |
| 2020 Q3 | 151.23 Million CNY | -44.77% |
| 2020 Q4 | 174.31 Million CNY | 15.26% |
| 2020 FY | - CNY | 4.1% |
| 2019 Q2 | 189.48 Million CNY | 9.75% |
| 2019 Q3 | 155.67 Million CNY | -17.84% |
| 2019 Q4 | 286.14 Million CNY | 83.81% |
| 2019 Q1 | 172.65 Million CNY | -37.13% |
| 2019 FY | - CNY | 9.74% |
| 2018 Q1 | 134.95 Million CNY | 6.51% |
| 2018 Q2 | 171.32 Million CNY | 26.95% |
| 2018 Q3 | 124.76 Million CNY | -27.18% |
| 2018 FY | - CNY | 30.16% |
| 2018 Q4 | 274.6 Million CNY | 120.09% |
| 2017 FY | - CNY | 18.0% |
| 2017 Q2 | 142 Million CNY | 52.22% |
| 2017 Q3 | 142.17 Million CNY | 0.12% |
| 2017 Q1 | 93.29 Million CNY | -30.24% |
| 2017 Q4 | 126.71 Million CNY | -10.87% |
| 2016 Q2 | 120.52 Million CNY | 55.27% |
| 2016 Q3 | 87.78 Million CNY | -27.16% |
| 2016 FY | - CNY | 4.78% |
| 2016 Q1 | 77.62 Million CNY | -58.89% |
| 2016 Q4 | 133.73 Million CNY | 52.34% |
| 2015 FY | - CNY | -0.18% |
| 2015 Q4 | 188.81 Million CNY | 359.75% |
| 2015 Q3 | 41.06 Million CNY | -58.71% |
| 2015 Q2 | 99.45 Million CNY | 30.2% |
| 2015 Q1 | 76.38 Million CNY | -50.69% |
| 2014 Q3 | 67.75 Million CNY | -29.12% |
| 2014 Q2 | 95.58 Million CNY | 28.71% |
| 2014 FY | - CNY | 23.82% |
| 2014 Q1 | 74.26 Million CNY | -66.01% |
| 2014 Q4 | 154.92 Million CNY | 128.65% |
| 2013 Q3 | 35.11 Million CNY | -64.62% |
| 2013 FY | - CNY | 23.03% |
| 2013 Q2 | 99.24 Million CNY | 957.27% |
| 2013 Q1 | -11.57 Million CNY | -105.1% |
| 2013 Q4 | 218.47 Million CNY | 522.13% |
| 2012 Q3 | 6.19 Million CNY | -77.01% |
| 2012 Q4 | 227.04 Million CNY | 3566.96% |
| 2012 FY | - CNY | -22.42% |
| 2012 Q1 | 16.19 Million CNY | -93.11% |
| 2012 Q2 | 26.92 Million CNY | 66.34% |
| 2011 Q1 | 76.96 Million CNY | 12.26% |
| 2011 FY | - CNY | -20.62% |
| 2011 Q4 | 234.97 Million CNY | 352.54% |
| 2011 Q3 | 51.92 Million CNY | 47.15% |
| 2011 Q2 | 35.28 Million CNY | -54.15% |
| 2010 FY | - CNY | -40.49% |
| 2010 Q1 | 195.41 Million CNY | 12.36% |
| 2010 Q3 | 71.54 Million CNY | -68.95% |
| 2010 Q4 | 68.55 Million CNY | -4.18% |
| 2010 Q2 | 230.41 Million CNY | 17.91% |
| 2009 FY | - CNY | 14.83% |
| 2009 Q2 | 114.7 Million CNY | 8.5% |
| 2009 Q3 | 731.01 Million CNY | 537.3% |
| 2009 Q1 | 105.72 Million CNY | -69.59% |
| 2009 Q4 | 173.92 Million CNY | -76.21% |
| 2008 Q1 | 108.73 Million CNY | 30.67% |
| 2008 Q4 | 347.64 Million CNY | 24.4% |
| 2008 Q3 | 279.46 Million CNY | 34.74% |
| 2008 Q2 | 207.4 Million CNY | 90.75% |
| 2008 FY | - CNY | 70.31% |
| 2007 Q3 | 163.07 Million CNY | 54.15% |
| 2007 Q4 | 83.21 Million CNY | -48.97% |
| 2007 Q2 | 105.78 Million CNY | 39.58% |
| 2007 Q1 | 75.79 Million CNY | -68.54% |
| 2007 FY | - CNY | 40.02% |
| 2006 Q2 | 86.27 Million CNY | -27.12% |
| 2006 Q4 | 240.87 Million CNY | 210.69% |
| 2006 Q1 | 118.39 Million CNY | 445.1% |
| 2006 FY | - CNY | 86.33% |
| 2006 Q3 | 77.52 Million CNY | -10.14% |
| 2005 FY | - CNY | -43.5% |
| 2005 Q4 | -34.3 Million CNY | -152.64% |
| 2005 Q3 | 65.17 Million CNY | -55.31% |
| 2005 Q2 | 145.85 Million CNY | 36.8% |
| 2005 Q1 | 106.62 Million CNY | -10.39% |
| 2004 Q4 | 118.98 Million CNY | 10.2% |
| 2004 FY | - CNY | -32.21% |
| 2004 Q3 | 107.97 Million CNY | -14.68% |
| 2004 Q1 | 135.38 Million CNY | -22.3% |
| 2004 Q2 | 126.55 Million CNY | -6.52% |
| 2003 FY | - CNY | 11.64% |
| 2003 Q1 | 218.67 Million CNY | 170.3% |
| 2003 Q2 | 293.12 Million CNY | 34.04% |
| 2003 Q4 | 174.23 Million CNY | 323.3% |
| 2003 Q3 | 41.16 Million CNY | -85.96% |
| 2002 Q4 | 80.89 Million CNY | -14.25% |
| 2002 Q1 | 124.37 Million CNY | 0.0% |
| 2002 Q3 | 94.34 Million CNY | -24.86% |
| 2002 Q2 | 125.55 Million CNY | 0.95% |
| 2002 FY | - CNY | 6.45% |
| 2001 FY | - CNY | 166.36% |
| 2000 FY | - CNY | -15.41% |
| 1999 FY | - CNY | 14.34% |
| 1998 FY | - CNY | -13.05% |
| 1997 FY | - CNY | 1.59% |
| 1996 FY | - CNY | 6.3% |
| 1995 FY | - CNY | -78.38% |
| 1994 FY | - CNY | 519.33% |
| 1993 FY | - CNY | 0.0% |